Vacuna del meningococo, ¿necesidad de revacunaciones?

Salleras, 2003, Dramatic decline of serogroup C meningococcal disease in Catalonia (Spain) alter a mass vaccination campaign with meningococcal C conjugated vaccine, Vaccine, 21, 729, 10.1016/S0264-410X(02)00590-X Zhang, 2002, Mucosal immune responses to meningococcal conjugate polysaccharide vaccines in infants, Pediatr Infect Dis J, 21, 209, 10.1097/00006454-200203000-00010 Pereiro, 2001, Epidemiological pattern of meningococcal disease in Valencia, Spain. Impact of a mass immunization campaign with meningococcal C polysaccharide vaccine, Scand J Infect Dis, 33, 581, 10.1080/00365540110026638 González de Aledo, 1998, Seroprevalencia de anticuerpos bactericidas frente al meningococo C en Cantabria despues de la campana de vacunacion, Rev Esp Salud Publica, 72, 365, 10.1590/S1135-57271998000400008 Delgado, 2000, Niveles de anticuerpos bactericidas contra meningococo C despues de la vacunacion a niños entre 2 y 6 anos en Andalucia, Rev Esp Salud Publica, 74, 433 Alcalá, 2000, Situación de la cepa epidémica de Neisseria Meningitidis C:2b:P1.2,5 despues de la vacunacion A+C, Rev Esp Salud Publica, 74, 377 Goicoechea, 2003, Evolución de la enfermedad meningococica en la poblacion infantil de la Comunidad Valenciana (1996–2000). Efectividad de la vacunacion meningococica A+B, Rev Esp Salud Publica, 77, 125 Skull, 2001, Meningococcal vaccination for adolescents? An economic evaluation in Victoria, J Pediatr Child Health, 37, 28S, 10.1046/j.1440-1754.2001.00652.x Zhang, 2001, Primary and Booster mucosal Immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to University students in the United Kingdom, Infect Immun, 69, 4337, 10.1128/IAI.69.7.4337-4341.2001 Richmond, 2000, Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine, J Infect Dis, 181, 761, 10.1086/315284 Pollard, 2000, Vaccines for prevention of meningococcal disease, Pediatr Infec Dis J, 19, 333, 10.1097/00006454-200004000-00015 Váazquez, 2002, Evaluación de la campana de inmunización frente a meningococo de serogrupo C en España, An Esp Pediatr, 57, 3 Balmer, 2002, Impact of meningococcal C conjugate vaccine in the UK, J Med Microbiol, 51, 717, 10.1099/0022-1317-51-9-717 Peter, 2001, Update on meningococcal vaccine, Pediatr Infect Dis J, 20, 311, 10.1097/00006454-200103000-00018 Trotter, 2002, Meningococcal serogroup C conjugate vaccination in England and Wales: coverage and initial impact of the campaign, Commun Dis Public Health, 5, 220 McLennan, 2000, Safety, immunogenicity and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial, Jama, 283, 2795, 10.1001/jama.283.21.2795 Richmond, 2001, Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers, J Infect Dis, 183, 160, 10.1086/317646 Ramsay, 2003, Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis, Bmj, 326, 365, 10.1136/bmj.326.7385.365 Bose, 2003, Effectiveness of meningococcal C conjugate vaccine in teenagers in England, Lancet, 361, 675, 10.1016/S0140-6736(03)12563-9 Salleras, 2003, Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain, Vaccine, 21, 725, 10.1016/S0264-410X(02)00589-3 2000, Vacuna conjugada contra el menincococo serogrupo C McLennan, 2001, Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy, J Infect Dis, 183, 97, 10.1086/317667 Borrow, 2002, Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United Kingdom, J Infect Dis, 186, 1353, 10.1086/344324